M
Mamizhidao
Mamizhidao is a Healthcare Company
About Mamizhidao
Shenzhen Yixin Technology Co., Ltd. operates Mamizhidao, a healthcare service platform established in 2014, focusing on maternal and child health for middle-class families in China. The company was founded by Liang Liang, who serves as the CEO and brings experience from Fortune 500 companies like GE, along with a background that includes a physics degree from Fudan University and an MBA from Hong Kong University of Science and Technology.
Mamizhidao's business architecture integrates online and offline services to create a comprehensive healthcare ecosystem. The online component consists of the "Mamizhidao" mobile application, which functions as a consultation platform connecting users with medical professionals. This app allows mothers to consult with obstetricians and pediatricians from top-tier hospitals. By 2016, the platform had already attracted 3.6 million users and 1,000 doctors, handling over 10,000 daily consultations. More recent figures indicate the user base has grown to over 6 million mothers and 3,000 doctors.
The business model generates revenue through its integrated services. The platform initially builds user trust and engagement through free online content and consultations, then channels users towards its offline network of physical clinics for in-person medical care. In 2020, Mamizhidao's pediatric clinics in Shenzhen were operationally integrated into the Tencent-backed Penguin Almond Group, enhancing its service capabilities and expanding its physical footprint as part of a broader strategy to build a comprehensive urban healthcare model.
The company has a significant funding history, starting with a 10 million RMB angel round from SoftBank China in January 2015. This was followed by a $10 million Series A in May 2015, a 100 million RMB Series B in March 2016 led by Fosun RZ Capital, and a Series B+ in December 2016. The most recent major funding event was a 150 million RMB Series C round in June 2018, with investors including Share Capital and SoftBank China, aimed at upgrading its service system.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Headquarters
- Shenzhen, China
- Open positions
- None listed
- Dealroom signal
- 0.4/100
- Industry
- Health
- Sector
- Health, Hospital, Hard Tech
- Links
- Website
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES C✓Equity / VC | Jun 2018 | $23M | $92M | Undisclosed | — |
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Mamizhidao on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Mamizhidao’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.